On June 20, 2024, Hualan Vaccine (301207.SZ) announced that the company repurchased its own shares for the first time through a share repurchase special securities account in a centralized bidding trading manner. As of June 30, 2024, the company has repurchased a total of 2,210,000 shares through the Shenzhen Stock Exchange trading system in a centralized bidding trading manner, accounting for 0.37% of the company's current total share capital. The highest transaction price was 18.13 yuan/share, the lowest transaction price was 17.07 yuan/share, and the total transaction amount was 38.7472 million yuan (excluding trading fees). The implementation of the repurchase meets the requirements of relevant laws and regulations and the company's established repurchase plan.
华兰疫苗(301207.SZ)：累计回购0.37%股份
Hualan Vaccine (301207.SZ): repurchased 0.37% of the shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.